Yu Yang, Wang Xiao-Hui, Hu Wen-Jie, Chen De-Hua, Hu Zi-Li, Li Shao-Qiang
Hepatic Pancreatobiliary Surgery Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University) Changsha, Hunan Province, 410005, People's Republic of China.
J Hepatocell Carcinoma. 2024 May 8;11:801-812. doi: 10.2147/JHC.S438850. eCollection 2024.
The patterns and risk factors of postsurgical recurrence of patient with hepatocellular carcinoma (HCC) with microvascular invasion (MVI) are not clarified. This study aimed to decipher and compare the postoperative recurrent patterns and the risk factors contributing to recurrence between MVI positive (MVI) and MVI negative (MVI) HCC after hepatectomy.
Patients with HCC who underwent hepatectomy in three Chinese academic hospitals between January 1, 2009, and December 31, 2018, were enrolled. Recurrent patterns included early (≤2 years) or late (>2 years) recurrence, recurrent sites and number, and risk factors of recurrence were compared between the MVIand MVI groups by propensity score-matching (PSM).
Of 1756 patients included, 581 (33.1%) were MVI, and 875 (49.8%) patients developed early recurrence. Compared with the MVI group, the MVI group had a higher 2-year recurrence rate in the PSM cohort (hazard ratio [HR], 1.82; 95% confidence interval [CI], 1.59-2.10; P < 0.001), and more patients with multiple tumor recurrence. Patients with early recurrence in the MVI group had a worse overall survival (OS) than those in the MVI group (HR, 1.24; 95% CI, 1.02-1.50; P = 0.034). Resection margin (RM) ≤1.0 cm is a surgical predictor of early recurrence for the MVI group (HR, 0.68; 95% CI, 0.54-0.87; P = 0.002), but not for the MVI group.
Compared to MVI HCC, MVI HCC tends to be early, multiple recurrence and lung and lymph node metastasis after resection. RM ≤1.0 cm is a surgical risk factor of early recurrence for patient with MVI.
微血管侵犯(MVI)的肝细胞癌(HCC)患者术后复发模式及危险因素尚不明确。本研究旨在解读并比较肝切除术后MVI阳性(MVI⁺)和MVI阴性(MVI⁻)HCC的术后复发模式及复发相关危险因素。
纳入2009年1月1日至2018年12月31日期间在三家中国学术医院接受肝切除术的HCC患者。复发模式包括早期(≤2年)或晚期(>2年)复发、复发部位及数量,并通过倾向评分匹配(PSM)比较MVI⁺和MVI⁻组之间的复发危险因素。
纳入的1756例患者中,581例(33.1%)为MVI⁺,875例(49.8%)患者出现早期复发。与MVI⁻组相比,MVI⁺组在PSM队列中的2年复发率更高(风险比[HR],1.82;95%置信区间[CI],1.59 - 2.10;P < 0.001),且多灶性肿瘤复发的患者更多。MVI⁺组早期复发患者的总生存期(OS)比MVI⁻组更差(HR,1.24;95% CI,1.02 - 1.50;P = 0.034)。切缘(RM)≤1.0 cm是MVI⁺组早期复发的手术预测因素(HR,0.68;95% CI,0.54 - 0.87;P = 0.002),但不是MVI⁻组的预测因素。
与MVI⁻ HCC相比,MVI⁺ HCC切除术后倾向于早期、多灶性复发以及肺和淋巴结转移。RM≤1.0 cm是MVI⁺患者早期复发的手术危险因素。